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Abstract
Background and Objectives—This study was designed to examine modes of cell death after
photodynamic therapy (PDT).
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Study Design—Murine leukemia L1210 cells and human prostate Bax-deficient DU145 cells were
examined after PDT-induced photodamage to the endoplasmic reticulum (ER). Phase contrast,
fluorescence and electron microscopy were used to identify changes in cellular morphology,
chromatin condensation, loss of mitochondrial membrane potential, and formation of
phagolysosomes. Western blots were used to assess the processing of LC3-I to LC3-II, a marker for
autophagy. Inhibitors of apoptosis and/or autophagy were used to delineate the contributions of the
two pathways to the effects of PDT.
Results—Both apoptosis and autophagy occurred in L1210 after ER photodamage with the latter
predominating after 24 hours. In DU145 cells, PDT conditions causing comparable cytotoxicity only
initiated autophagy. PI3-kinase inhibitors suppressed autophagy in both cell lines as indicated by
inhibition of vacuolization and LC3 processing.
Conclusions—Both autophagy and apoptosis were observed in L1210 cells following ER
photodamage. In the Bax-deficient DU145 cell line only autophagy was observed. Current
information suggests that autophagy can function as either a survival or death pathway. We propose
that in the context of PDT, this may also be true.
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Introduction
Photodynamic therapy (PDT) involves the photosensitization of neoplastic cells and tissues
with porphyrins or related structures that catalyze, upon irradiation, formation of reactive
oxygen species [1]. While effects of PDT on tissues also include vascular shutdown and the
evoking of immunologic responses, there is also an element of direct cell kill that can reduce
the neoplastic cell population by 2–3 logs [1].
It was initially believed that PDT killed cells via necrosis. In 1991, Oleinick's group provided
data indicating that PDT could trigger the induction of apoptosis [2]. Numerous subsequent
studies have documented the induction of apoptosis in a variety of cell types, by an array of
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different sensitizers, and a variety of mechanisms. The cytotoxicity of PDT protocols cannot
be totally explained by the induction of apoptosis or necrosis. Cells lacking procaspase-3 [3]
or Bax [4] die after PDT, but do not display the characteristics of necrotic or apoptotic cell
death.
Autophagy is a process whereby cytosol and organelles become encased in vacuoles termed
autophagosomes. Following fusion with lysosomes, the contents of the autophagosomes are
digested and recycled [5]. Autophagy was originally characterized as a survival response to
nutrient deprivation and other forms of cellular stress. However, studies within the past decade
clearly indicate that the induction of autophagy can sometimes lead to cell death [6–12]. Indeed,
autophagic death is important during development [13], and appears to mediate the cytotoxicity
of some anti-cancer agents [14].
Autophagic cell death has morphological and biochemical features that are distinct from both
apoptosis and necrosis [15]. Because autophagy develops in a sequential fashion with defined
characteristics, it is considered to be a second type of programmed cell death (sometimes
referred to as ‘type II cell death’). In this study, we assessed the possibility that PDT may
induce autophagy, and that type II death contributes to the cytotoxicity occurring in PDT
protocols.
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Materials and Methods
Chemicals and Biologicals
The photosensitizer 9-capronyloxytetrakis (methoxyethyl) porphycene (CPO) was synthesized
as described Ref. [16]. Amino acids and tissue culture media were purchased from SigmaAldrich (St. Louis, MO), sterile horse serum from Atlanta Biologicals (Lawrenceville, GA),
and fluorescent probes from Molecular Probes (Eugene, OR). Other reagents were provided
by Calbiochem and Sigma-Aldridge (St. Louis).
Cell Propagation
Murine leukemia L1210 cells were grown in sealed flasks using Fisher's Medium (SigmaAldrich) containing 10% horse serum and supplemented with 1 mM glutamine, 1 mM
mercaptoethanol and gentamicin. Since Fisher's medium is no longer commercially available,
an approximation of the formula was prepared by supplementing the α-MEM formulation
(GIBCO-BRL, Grand Island, NY) with MgCl2 (45 mg/L), methionine (75 mg/L),
phenylalanine (30 mg/L), valine (30 mg/L) and folic acid (9 mg/L). The DU145 cell line was
propagated as described in Ref. [17].
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Western Blots
Cells were lysed and extracts prepared for Western blot analysis as previously described [18].
Aliquots containing 40 μg of protein were used for these assays. Immunofluorescence signals
were detected with Vistra ECF western blot reagent (Amersham Biosciences Corp.,
Piscataway, NJ) using the Storm imaging system (Molecular Dynamics, Sunnyvale, CA). A
rabbit polyclonal antibody raised to microtubule-associated protein LC3 was the gift of Dr.
Masahiro Shibata (Osaka University Graduate School of Medicine, Japan).
Viability
Clonogenic assays were used to determine loss of viability after PDT. Serial dilutions of L1210
cell suspensions were plated on soft agar. After 7–9 days growth in a humidified chamber under
5% CO2, colonies were counted and compared with untreated control values. All such
experiments were carried out in triplicate. For DU145, sparsely plated cultures were treated,
and the number of colonies that developed were compared with control values.
Lasers Surg Med. Author manuscript; available in PMC 2009 September 23.
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PDT Protocols

NIH-PA Author Manuscript

L12106 cells (7 mg/ml, 3.5×10 cells/ml) were incubated in Fischer's medium with 25 mM
HEPES buffer pH 7.4 replacing NaHCO3, to promote pH maintenance at high cell densities.
PDT studies involved incubation for 30 minutes at 37°C with 2 μM CPO. Cells were then
resuspended in fresh medium and irradiated at 10°C. The light source was a 600 W quartzhalogen lamp with IR radiation attenuated by a 10 cm layer of water and an 850 nm low-pass
filter. Irradiation was carried out at 600–650 nm using appropriate band-pass filters (Oriel,
Stratford, CT). The cell suspensions were then incubated for an additional time at 37°C as
specified in the text.
DU145 cells were grown on cover slips in 3.5-cm diameter dishes. After a 30 minutes
sensitization with 2 μM CPO the medium was replaced, and irradiation was carried out using
the light source defined above. Cells were then incubated at 37°C until further procedures were
carried out.
Wortmannin, LY294002 or zDEVD-fmk were added to culture medium at the time of
sensitization.
Phase-Contrast and Fluorescence Microscopy
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All images were acquired using a Nikon Eclipse E600 microscope and a SenSys CCD camera
(Photometrics, Tucson, AZ). Images were processed using MetaMorph software (Universal
Imaging, Downington, PA). A Uniblitz shutter was used to control exposure of the stage to the
excitation source. This shutter was configured to open and close with the camera shutter,
thereby minimizing photobleaching of fluorescence.
So as to permit comparisons of image brightness, fluorescence images for each probe were
acquired under the same exposure conditions. The gray-scale of the 8-bit images ranged from
0 (black) to 256 (white). Image analysis was carried out using the Integrated Morphometry
Analysis program provided by MetaMorph. Fluorescence intensity is expressed as the
integrated value of all pixels per cell that exceed the inclusive threshold value set at 45.
Electron Microscopy
For these studies, L1210 cells were fixed with glutaraldehyde and osmium tetraoxide, then
dehydrated with ethanol. The cell pellets were embedded in epon resin and cut with an
ultramicrotome to 70 nm thick.
Fluorescent Probes and Procedures
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Fluorescent probes used were Höchst dye 33342 (3 μM, using a 5 minutes incubation at 37°
C) for examination of nuclear morphology, tetramethyrhodamine methyl ester (TMRM, 1 μM
for 5 minutes at 37°C) to assess mitochondrial membrane potential, and monodansylcadaverine
(MDC, 10 μM, 10 minutes incubation) for imaging enhanced lysosomal activity and lysosomeautophagosome fusion products [19]. After labeling, cells were washed once with fresh growth
medium and examined by phase-contrast and fluorescence microscopy. Excitation
wavelengths were 360–380 nm (HO342, MDC), and 510–560 nm (TMRM). Interference filters
were used to isolate the emission fluorescence of HO342 (400–450 nm), MDC (520–560 nm)
and TMRM (550–650 nm).
DEVDase Assays
Activation of DEVDase after irradiation was assessed using the fluorogenic substrate DEVDR110 as described previously [20]. L1210 cells were incubated at 37°C for 10 minutes after
irradiation, prior to being harvested for subsequent analyses.
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Statistical Procedures
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Statistical significance was evaluated by a paired t-test. Differences are assumed to be
significant if P<0.01.

Results
PDT-Induced Apoptosis and Autophagy: L1210 Cells
Phase-contrast and HO33342 labeling of control cells are shown in Figure 1, panels A and E.
Sixty minutes after irradiation of CPO-sensitized cells (LD90 conditions), an apoptotic
morphology was exhibited in approx. fifty percentage of cells, as detected by HO33342
labeling (Fig. 1F). Some vacuoles can be seen in some cells of the corresponding phase-contrast
image of the same field (Fig. 1B). When cells were incubated with wortmannin prior to
irradiation a greater percentage of the cells were smaller and displayed apoptotic nuclei (Figs.
1C and G). After 24 hours, the apoptotic cells had disappeared from the population and mainly
swollen cells with extensive vacuole formations were observed (Fig. 1D and H).
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At a higher magnification, the pattern of MDC labeling in control cells can be observed (Fig.
1M), representing the lysosomal/endosomal population. The pattern was substantially different
24 hours after an LD90 PDT dose, with vacuolated cells (Fig. 1J) showing strong MDC labeling
at their periphery (Fig. 1N). In addition to its ability to label normally acidic organelles, MDC
has an affinity for fused autophagosomes [19]. At this time, most of the cell population was
impermeable to propidium iodide (data not shown). After an additional 48 hours (72 hours post
PDT), the predominant cell population exhibited a chaotic morphology (Fig. 1K) that stained
weakly with HO33342 (Fig. 1O). Virtually all PDT-treated cells at this time point were
permeable to propidium iodide. In contrast, cells exhibited a much more normal morphology
72 hours after PDT when both zDEVD and wortmannin were present (Fig. 1L), although the
MDC labeling pattern was indistinct (Fig. 1P). HO33342 labeling revealed no evidence of
apoptosis, and the cells were impermeable to propidium iodide (data not shown).
Electron microscopy demonstrated that the vacuoles visualized 24 hours after PDT were not
empty (Fig. 2).
PDT-Induced Death of DU145 Cells
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The DU145 prostate cell line lacks Bax [17]. This line dies following sensitization with a
mitochondrial PDT sensitizer and irradiation, but the mode of death appears to be neither
necrotic nor apoptotic [4]. We found that DU145 cells can be killed by PDT protocols
employing the endoplasmic reticulum (ER) photosensitizer CPO. However, death was not
accompanied by the development of apoptotic morphological features (compare Fig. 3A and
B), loss of mitochondrial potential (compare Fig. 3G and H), formation of condensed nuclear
chromatin (Fig. 3I), or the activation of pro-caspases 3/7 (data not shown). Instead, CPO
sensitized DU145 cultures treated with an LD90 PDT dose resulted in the appearance of
vacuolated cells (Fig. 3B) that labeled strongly with MDC (Fig. 3E). Co-treatment of CPOsensitized/irradiated DU145 cultures with the PI3-kinase inhibitor LY294002 effectively
suppressed both vacuolization (Fig. 3C) and staining with MDC (Fig. 3F). These latter studies
are significant since PI3-kinase activity is required for the development of autophagy [5,6].
These data suggest that CPO-mediated photo killing of the DU145 cell line was associated
with the induction of autophagy and not apoptosis.
A further analysis of MDC labeling of control cells and cells 24 hours after an LD90 PDT dose
was carried out using the MetaMorph Integrated Morphometry Analysis, using 8 bit images
(256 step gray-scale). Cells were digitally processed to exclude all pixels with a gray-scale
value below 45, that is, the darker pixels. The average gray value was then assessed for each
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cell. The analysis (Table 1) indicates that there was approximately a fourfold increase in the
number of bright pixels after PDT compared with untreated controls and that this difference
was abolished in the presence of 100 nM wortmannin.
LC3 Processing
Upon the induction of autophagy, the cytosolic protein LC3-I is covalently linked to
phosphatidylethanolamine to yield LC3-II, which subsequently associates with the
autophagosome [21]. Conversion of LC3-I to LC3-II has been used as a marker for autophagy
[20]. Irradiation of L1210 or DU145 cultures that had been presensitized with CPO resulted
in a conversion of LC3-I to LC3-II. LC3 processing was markedly decreased when either cell
line was preincubated with wortmannin (100 nM) prior to irradiation. In contrast, incubation
with 50 μM zDEVD-fmk prior to PDT potentiated LC3-I processing (Fig. 4).
Effects of Apoptosis and Autophagy Inhibitors
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A study of the effects of inhibitors of apoptosis versus autophagy on DEVDase activation
provided additional information on the relationship between the two processes (Table 2). In
these studies L1210 cultures were exposed to CPO/PDT conditions yielding a 90% loss of
viability. DEVDase activity was clearly increased consistent with the initiation of apoptosis,
and this activation was abolished when the caspase 3/7 inhibitor zDEVD-fmk was present. In
agreement with the chromatin condensation studies depicted in Figure 1F and G, DEVDase
activation was elevated when autophagy was impaired by the presence of wortmannin, but
reduced to the control value when both inhibitors were present.

Discussion
In the current study we used multiple criteria to score for the development of autophagy.
Amongst our criteria were: (1) The development of multiple large vacuoles whose periphery
was labeled with MDC; (2) suppression of vacuole formation and MDC labeling by inclusion
of a PI3-kinase inhibitor; (3) demonstration of the vacuoles not being empty by electron
microscopy; (4) conversion of LC3-I to LC3-II; (5) maintenance of mitochondrial membrane
potential; and (6) the absence of nuclear condensation. A comparison of panels 1A and 1D,
and of 1I and 1J indicate that the vacuolated cells are larger than their non-treated counterparts.
We conclude that PDT-induced ER photodamage induces autophagy in both L1210 and DU145
cultures. To the best of our knowledge, these are the first studies to document PDT-induced
autophagy.
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The data presented in Figure 1 indicate that both apoptosis and autophagy occur in L1210
cultures following PDT with CPO. The appearance of apoptotic cells, as well as their
disappearance from the cultures, occurred quickly after PDT with CPO. Apoptotic cells were
obvious within an hour of PDT, and disappeared from the cultures within the subsequent 23
hours. In contrast, the appearance of cells with autophagic characteristics required ∼24 hours.
The relative percentages of L1210 cells undergoing apoptosis or autophagy following PDT
could be experimentally manipulated. Preincubation with the PI3-kinase inhibitors
wortmannin or LY294002 prior to PDT promoted the morphological appearance of apoptosis
(compare Fig. 1F with G) and DEVDase activation (Table 2), and suppressed vacuole
formation, MDC labeling, and the conversion of LC3-I to LC3-II in L1210 cultures. These
effects probably reflect inhibitions of both the class III PI3 kinases needed for autophagy, and
the class I enzymes that activate the anti-apoptotic Akt/PKB pathway [12]. Conversely,
pretreatment with the caspase-3/7 inhibitor zDEVD-fmk enhanced the conversion of LC3-1 to
LC3-II (Fig. 4), and the percentage of L1210 cells developing vacuoles (data not presented).
We propose that after PDT there is an equilibrium established between autophagy and
apoptosis, with inhibition of either process leading to enhanced activity by the other. This
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inhibition could be mediated either pharmacologically, or as in the case of DU145 cells, reflect
a defect in one of the two pathways that results in a default activation of the other.
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Although autophagy was originally described as a cell survival response, numerous studies
have also implicated it as a death pathway [6–12]. In the case of PDT with CPO it appears that
the induction of autophagy also leads to cell death. The basis for this death, in the context of
PDT, possibly lies in the ability of CPO [20], as well as another sensitizer [22] to photodamage
Bcl-2. Specifically, the down regulation of Bcl-2 expression by molecular approaches has been
shown to induce/facilitate the development of autophagy [23,24].
Oleinick's group had reported that photo killing was not affected in cell lines lacking procaspase-3 [3], and proposed that apoptosis may merely be a means for disposing of dead cells.
A similar role may hold for autophagy. As in apoptosis, there is a flipping of phosphatidylserine
to the cell surface during autophagy [25]. Externalization of this lipid enables the dying cell to
be recognized and phagocytized, thus avoiding an inflammatory response.
In the context of PDT, it is interesting to note that autophagy can result in class II presentation
of antigens derived from cytosolic proteins [26]. The autophagic response to PDT may
therefore provide an explanation for the finding that treatment of tumor cells with low-dose
PDT can yield anti-tumor vaccines [27].
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Fig. 1.

Effects of an LD90 PDT dose (CPO) on morphology and fluorescence labeling of L1210 cells.
A–D, I–L: phase-contrast images; (E–H, M–P) fluorescence. A, E: controls (HO33342
fluorescence); (B, F) 1 hour after irradiation (HO33342 fluorescence); (C, G) 1 hour after
irradiation, cultures preincubated with 100 nM wortmannin prior to irradiation (HO33342
fluorescence); (D, H) cells 24 hours after irradiation (HO33342 fluorescence); (I, M) controls
(MDC labeling); (J, N) cells 24 hours after irradiation (MDC labeling); (K, O) cells 72 hours
after irradiation (HO33342 fluorescence). L, P: Cells 72 hours after irradiation with zDEVD
and wortmannin present (MDC labeling). White bars apply to each row and represent 10 m for
(A–H) and 20 μ for (I–P).
Lasers Surg Med. Author manuscript; available in PMC 2009 September 23.
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Fig. 2.

Electron microscopy showing fine structure of vacuoles in L1210 cells 24 hours after an
LD90 PDT dose (CPO).
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Fig. 3.

Phase-contrast (A–C, G) and fluorescence (D–F, H, I) images of DU145 cells. A, D: control
cells (phase-contrast vs. MDC labeling); (B, E) cells 24 hours after an LD90 PDT dose using
CPO (phase-contrast vs. MDC); (C, F) phase contrast versus MDC labeling 24 hours after PDT
with LY294002 (25 μM) present. Images (G–I) are of a single cell 24 hours after PDT: (G)
phase-contrast, (H) TMRM labeling showing maintenance of the mitochondrial membrane
potential, (I) HO33342 labeling showing absence of apoptotic morphology. White bars=20 μ.
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Fig. 4.

Western blot analyses of LC3-I processing. From the left: control L1210 cells; cells 24 hours
after an LD90 PDT dose with CPO; 24 hours after PDT with 100 nM wortmannin present during
sensitization with CPO; 24 hours after PDT with 50 μM zDEVD-fmk present during the
sensitization with CPO; control DU145 cells; DU145 cells 24 hours after an LD90 PDT dose
with CPO; and 24 hours after PDT with 100 nM wortmannin present during the sensitization
with CPO. Each lane contained 40 μg of protein.
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TABLE 1

Integrated Morphometry Analysis of MDC Labeling of DU145 Cells
Treatment
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Relative Intensity

n

None

100 ± 12

25

PDT

351 ± 44*

29

95 ± 18

23

PDT + wortmannin

Effects of an LD90 PDT dose with CPO on pixel brightness of MDC fluorescence in DU145 cells. Data represent the mean ± SD for the specified number
of cells.
*

Statistical significance (P < 0.01) compared with controls.
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TABLE 2

Effects of zDEVD-fmk and Wortmannin on DEVDase Activation after PDT
Treatments

DEVDase activity

NIH-PA Author Manuscript

None

0.39 ± 0.03

PDT

8.5 ± 0.53

PDT + zDEVD-fmk

0.66 ± 0.21*

PDT + wortmannin

10.3 ± 0.71*

PDT + both

0.48 ± 0.23*

Effects of an LD90 PDT dose with CPO on DEVDase activity of L1210 cells. Where specified, wortmannin (100 nM) and/or zDEVD-fmk (50 μM) were
present at the time of loading with sensitizer. DEVDase activity is expressed in terms of nmol product/min/mg protein. Data represent the mean ± SD for
three determinations.
*

Statistical significance (P < 0.01) compared with PDT-treated cells without additions.
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